Parental Understanding of Their Child’s Germline Genomic Testing: Intent of Disclosure to Their Child and Family

Author:

Mandrell Belinda N.1ORCID,Blake Alise K.2,Sharp Katianne M. Howard3,Gattuso Jami S.1,McGee Rose B.2,Harrison Lynn2,Ouma Annastasia2,Caples Mary1,Johnson Liza-Marie4,Nichols Kim E.2ORCID

Affiliation:

1. Division of Nursing Research, Department of Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA

2. Division of Cancer Predisposition, Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA

3. Department of Psychology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA

4. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA

Abstract

Genomic testing is becoming increasingly common in the care of pediatric patients with cancer. Parental understanding of germline results and their intent and timing of results disclosure to their child and family may have significant implications on the family unit. The purpose of this study was to examine parental understanding of germline genomic results and plans for disclosure to their child and other relatives. Semi-structured interviews were conducted with 64 parents of children with cancer, approximately eight weeks after parents had received their child’s results. Parents of children with negative results (n = 20), positive results (n = 15), or variants of uncertain significance (n = 29), were interviewed. Fifty-three parents (83%) correctly identified their child’s results as negative, uncertain, or positive. Most parents had disclosed results to family members; however, only 11 parents (17%) acknowledged discussing results with their child. Most parents delayed disclosure due to the young age of their child at the time of testing. In summary, most parents appropriately described their child’s germline genomic results, yet few discussed the results with their child due to age. Families should be followed with supportive counseling to assist parents in the timing and content of result disclosure to their children.

Funder

National Cancer Institute

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference30 articles.

1. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehen-sive DNA and RNA Sequencing;Newman;Cancer Discov.,2021

2. The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer;Kesserwan;Am. Soc. Clin. Oncol. Educ. Book,2016

3. Growing up in the genomic era: Implications of whole-genome sequencing for children, families, and pediatric practice;Wade;Annu. Rev. Genom. Hum. Genet.,2013

4. (2023, October 10). National Society of Genetic Counselors, Policy/Position Statement. Genetic Testing of Minors for Adult-Onset Conditions. Available online: https://www.nsgc.org/POLICY/Position-Statements/Position-Statements/Post/genetic-testing-of-minors-for-adult-onset-conditions.

5. Reliability of self-reported family history of cancer in a large case-control study of lymphoma;Chang;J. Natl. Cancer Inst.,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3